Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Hagerty Commences Warrant Exchange Offer and Consent Solicitation
-
Hyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024
-
Forrester Appoints Technology Marketing Expert Cory Munchbach To Its Board
-
Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
-
Repare Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
Sypris Appoints Michael D. Sedgwick as Vice President and General Manager of Sypris Electronics, LLC
-
PNM Resources Announces Offering of Junior Subordinated Convertible Notes due 2054
-
AvidXchange to Participate in Upcoming Investor Conferences
-
Leading Restaurant Executive Joins Dutch Bros Board of Directors
-
Camping World Announces Succession Plans
-
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders
-
Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio
-
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Affirm to Webcast CFO Fireside Chat on June 14, 2024
-
National Storage Affiliates Trust Announces Internalization of its PRO Structure
-
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Electromed, Inc. to Participate in the 2024 Sidoti June Small-Cap Virtual Conference
-
E*TRADE from Morgan Stanley Releases Monthly Sector Rotation Study
-
Kernel Group Holdings, Inc. Extends Period to Consummate Initial Business Combination
-
Lavoro Reports Fiscal Third Quarter 2024 Earnings Results¹
-
Sonos Announces Participation in Maxim Group Virtual Tech Conference
-
SECURITIES FRAUD INVESTIGATION: Investors of CAE, Inc. (NYSE: CAE) Who Lost Money on Company Impairment Charges are Encouraged to Contact BFA Law
-
Outset Medical to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
-
GitLab Reports First Quarter Fiscal Year 2025 Financial Results
-
Healthcare Realty Trust Provides Update on Capital Allocation Progress
-
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool
-
Safe Bulkers, Inc. Announces Agreement for the Acquisition of One Japanese Kamsarmax Class Dry-bulk Vessel
-
Publication relating to transparency notifications
-
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
-
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
-
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
-
BIOGEN 50 DAY NOTICE: Investors of Biogen Inc. (Nasdaq: BIIB) are Encouraged to Contact BFA Law Before July 2024 Deadline in Securities Fraud Class Action
-
ACQUISITION NEWS: Squarespace’s (NYSE: SQSP) $44 Buyout Offer is Being Investigated for Being Too Low, Shareholders are Encouraged Contact BFA Law
-
ACQUISITION NEWS: Cerevel’s (Nasdaq: CERE) $45 Merger Offer is Being Investigated for Being Too Low, Shareholders are Encouraged Contact BFA Law
-
WIDEOPENWEST MERGER STATUS: WideOpenWest’s $4.80 Bid Criticized by LB Partners, Shareholders are Encouraged to Contact BFA Law About Your Rights
-
PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024
-
Coveo Reports Fourth Quarter and Fiscal 2024 Financial Results
-
FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors
-
SECURITIES FRAUD INVESTIGATION: UiPath, Inc. (NYSE: PATH) CEO Resigns, Investors Who Lost Money are Encouraged to Contact BFA Law
-
Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024
-
Wellfield Announces Shares for Debt Transaction
-
Monroe Capital Corporation Announces Second Quarter Distribution of $0.25 Per Share
-
MAYA ROMANOFF INTRODUCES THREE NEW CAPTIVATING COLLECTIONS
-
HealthEquity Reports First Quarter Ended April 30, 2024 Financial Results
-
BARK Reports Fourth Quarter and Fiscal Year 2024 Results
-
Celcuity To Participate in Jefferies Global Healthcare Conference
-
Thornburg Income Builder Opportunities Trust Announces Distribution
